The potential role of platelets in the consensus molecular subtypes of colorectal cancer
- PMID: 28681242
- DOI: 10.1007/s10555-017-9678-9
The potential role of platelets in the consensus molecular subtypes of colorectal cancer
Abstract
The consensus molecular subtypes (CMS) in colorectal cancer (CRC) represent distinct molecular subcategories of disease as reflected by comprehensive molecular profiling. The four CMS subtypes represent unique biology. CMS1 represents high immune infiltration. CMS2 demonstrates upregulation of canonical pathways such as WNT signaling. Widespread metabolic changes are seen in CMS3. CMS4 represents a mesenchymal phenotype with hallmark features including complement activation, matrix remodeling, angiogenesis, epithelial-mesechymal transition (EMT), integrin upregulation and stromal infiltration. In contrast to this new paradigm, a number of observations regarding CRC remain disconnected. Cancers are associated with thrombocytosis. Venous thromboembolic events are more likely in malignancy and may signify worse prognosis. Aspirin, an anti-platelet agent, has been linked in large observational studies to decrease incidence of adenocarcinoma and less advanced presentations of cancer, in particular CRC. Inflammatory bowel disease is a risk factor for CRC. Gross markers to recognize the immunothrombotic link such as the platelet to lymphocyte ratio are associated with poorer outcomes in many cancers. Platelets are increasingly recognized for their dual roles in coordinating the immune response in addition to hemostasis. Here, we explore how these different but related observations coalesce. Platelets, as first responders to pathogens and injury, form the link between hemostasis and immunity. We outline how platelets contribute to tumorigenesis and how some disconnected ideas may be linked through inflammation. CMS4 through its shared mechanisms has predicted platelet activation as a hallmark feature. We demonstrate a platelet gene expression signature that predicts platelet presence within CMS4 tumors.
Keywords: CMS4; Circulating tumor cells; Colorectal cancer; Consensus molecular subtype; Extravasation; Inflammation; Metastasis; Platelet; Platelet-lymphocyte ratio; Platelets; TCIPA; Thrombosis.
Similar articles
-
Consensus molecular subtype classification of colorectal adenomas.J Pathol. 2018 Nov;246(3):266-276. doi: 10.1002/path.5129. Epub 2018 Aug 31. J Pathol. 2018. PMID: 29968252 Free PMC article.
-
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.Eur J Cancer. 2019 Dec;123:118-129. doi: 10.1016/j.ejca.2019.09.008. Epub 2019 Nov 1. Eur J Cancer. 2019. PMID: 31678770
-
Phenotypic subtypes predict outcomes in colorectal cancer.Acta Oncol. 2023 Mar;62(3):245-252. doi: 10.1080/0284186X.2023.2183779. Epub 2023 Mar 3. Acta Oncol. 2023. PMID: 36867078
-
Molecular pathological classification of colorectal cancer.Virchows Arch. 2016 Aug;469(2):125-34. doi: 10.1007/s00428-016-1956-3. Epub 2016 Jun 20. Virchows Arch. 2016. PMID: 27325016 Free PMC article. Review.
-
[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].Bull Cancer. 2016 Jul-Aug;103(7-8):643-50. doi: 10.1016/j.bulcan.2016.05.007. Epub 2016 Jun 23. Bull Cancer. 2016. PMID: 27345450 Review. French.
Cited by
-
Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer.Front Immunol. 2023 Jun 19;14:1160052. doi: 10.3389/fimmu.2023.1160052. eCollection 2023. Front Immunol. 2023. PMID: 37404825 Free PMC article.
-
Back to the Colorectal Cancer Consensus Molecular Subtype Future.Curr Gastroenterol Rep. 2019 Jan 30;21(2):5. doi: 10.1007/s11894-019-0674-9. Curr Gastroenterol Rep. 2019. PMID: 30701321 Free PMC article. Review.
-
Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis.J Community Hosp Intern Med Perspect. 2020 Oct 29;10(6):514-520. doi: 10.1080/20009666.2020.1816276. J Community Hosp Intern Med Perspect. 2020. PMID: 33194120 Free PMC article.
-
Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer.Front Oncol. 2019 Sep 24;9:960. doi: 10.3389/fonc.2019.00960. eCollection 2019. Front Oncol. 2019. PMID: 31612109 Free PMC article.
-
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.Onco_target. 2018 May 25;9(40):25860-25876. doi: 10.18632/onco_target.25395. eCollection 2018 May 25. Onco_target. 2018. PMID: 29899827 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical